SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-24-000071
Filing Date
2024-08-09
Accepted
2024-08-09 17:10:07
Documents
48
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks-20240630.htm   iXBRL 10-Q 506148
2 EX-31.1 slrx20240630ex-311.htm EX-31.1 8876
3 EX-31.2 slrx20240630ex-312.htm EX-31.2 8666
4 EX-32.1 slrx20240630ex-321.htm EX-32.1 6204
  Complete submission text file 0001615219-24-000071.txt   2856280

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20240630.xsd EX-101.SCH 21432
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20240630_cal.xml EX-101.CAL 23209
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20240630_def.xml EX-101.DEF 83725
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20240630_lab.xml EX-101.LAB 283548
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20240630_pre.xml EX-101.PRE 191630
51 EXTRACTED XBRL INSTANCE DOCUMENT flks-20240630_htm.xml XML 233315
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 241193938
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)